Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ MTB/MDR/XDRe Detection, Allplex™ MTB/MDRe Detection, Allplex™ MTB/XDRe Detection. Based on Seegene's proprietary DPO™ and TOCE™ technology, these assays are multiplex real-time PCR assay that detects and identifies?Mycobacterium tuberculosis (MTB) and 25 mutations associated with Multi-Drug Resistance (MDR) and 13 mutations associated with Extensively Drug Resistance (XDR). These assays enable to deliver MTB and Drug-resistant TB result in one day, which helps effective management of tuberculosis.
Oct 29, 2018｜ Allplex™ MTB/XDRe Detection
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Anyplex™ MTB/NTMe Real-time Detection. This assay is a Real-time PCR assay to detect simultaneously Mycobacterium tuberculosis dissociated from non-tuberculosis mycobacteria and include whole process control for assay validity.
May 12, 2017｜ Anyplex™ MTB/NTMe Real-time Detection
Tuberculosis is caused by Mycobacterium tuberculosis infection and it’s mostly transmitted through the air. Recently, the number of drug- resistant mycobacterium tuberculosis has been increased in worldwide due to the spread of drug-resistant mycobacterium tuberculosis infection or improper treatment when tuberculosis is first diagnosed. The Anyplex™ II MTB/MDR/XDR Detection has been specifically designed to address this unmet medical need through the simultaneous detection, Screening of MTB, MDR-TB and XDR-TB contributing to TB infection. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this homogeneous assay performs on standard existing real-time PCR instrumentation to detect, MTB, 25 MDR mutations and 13 XDR mutations. This product can help you to properly manage the tuberculosis and provides effective treatment guidelinesAnyplex™ II MTB/MDR/XDR? DetectionSimultaneous detection of MTB, MDR-TB and XDR-TBAnyplex™ II MTB/MDR/XDR Detection detects MTB, MDR-TB and XDR-TB in a single real-time PCR.
Sep 14, 2012｜ Anyplex™Ⅱ MTB/MDR/XDR Detection
Anyplex™ plus MTB/NTM/DR-TB Detection Detection and discrimination of MTB/NTM & MDR-TB Seegene's Anyplex™ plus MTB/NTM/DR-TB Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Nov 17, 2011｜ Anyplex™ plus MTB/NTM/DR-TB Detection
Seegene has launched Magicplex™ Sepsis Real-time Test
Jul 25, 2011｜ Anyplex™ plus MTB/NTM/MDR
Magicplex™ TB/MDR Real-time TestMagicplex™ TB/MDR Real-time Test detects Mycobacterium tuberculosis (MTB) and screens Multidrug-resistant Mycobacterium tuberculosis (MDR-TB) on Real-time PCR.
Dec 01, 2010｜ Magicplex TB/MDR Real-time Test
Detection of Mycobacterium tuberculosis Seegene's Magicplex™ MTB Real-time Test has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Aug 16, 2010｜ Magicplex MTB Real-Time Test
Anyplex™ MTB/NTM Real-time DetectionIdentification of MTB dissociated from NTM Seegene's Anyplex™ MTB/NTM Real-time Detection?has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jul 12, 2010｜ Anyplex™ MTB/NTM Real-time Detection